Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Nov 11, 2021 10:15am
162 Views
Post# 34114592

RE:RE:RE:RE:RE:RE:Is this the death watch for this POS

RE:RE:RE:RE:RE:RE:Is this the death watch for this POS

Wyndewest, what you describe as Thomvest playing the long game is exactly what it is going on here when you retrace the steps over the past several years. We'll have to wait and see but it's definitely a very viable theory especially after they did the recap. I just hope that they didn't work with some offshore hedge funds on the Short from $3.60 but it's how big guys make bank. 


wyndewest wrote: The whole Thomvest takeover has been painful to watch/be part of.  Clearly Thomvest doesn't want to and never did want to become a leading Biotech Compnay like Prometic wanted. No, but they did want their investment back from Prometic and they got it back in spades through the takeover and at the expense of the Prometic shareholders The word corporate raiders comes to mind. BUT I also believe they saw the HUGE financial potential in 4050. It would be to their advantage to sell or partner with a multinational company like Boehringher. Thomvest  contols the patents (not Pierre Laurin and certainly not Liminal). Thomvest is going to scuttle Liminal making it clear the company as it stands has no future. Thomvest (Peter Thomson) is playing the long game. I believe the patents/technology will be sold or a silent partnership formed through some backdoor agreement. The only winner will be Peter Thompson NOT Liminal. THIS IS JUST MY OPINION.  I guess we'll find out soon enough.

 

<< Previous
Bullboard Posts
Next >>